Cisplatin and its dibromido analogue: a comparison of chemical and biological profiles

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Biometals

• Publication date

  2016-04-16

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s10534-016-9934-4PMID 27086032
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• cis-Pt I2(NH3)2: a reappraisal.

  2015cited by this paper
• Understanding and improving platinum anticancer drugs--phenanthriplatin.

  2014cited by this paper
• Role of Autophagy in Cisplatin Resistance in Ovarian Cancer Cells*

  2014cited by this paper
• Synthetic methods for the preparation of platinum anticancer complexes.

  2013cited by this paper
• Peculiar features in the crystal structure of the adduct formed between cis-PtI2(NH3)2 and hen egg white lysozyme.

  2013cited by this paper
• ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme.

  2007cited by this paper
• Cisplatin: mode of cytotoxic action and molecular basis of resistance

  2003cited by this paper
• Equilibria and kinetics of the intercalation of Pt-proflavine and proflavine into calf thymus DNA.

  2003cited by this paper
• DNA repair and cisplatin resistance in non-small-cell lung cancer.

  2002cited by this paper
• High-dose cisplatin in the treatment of advanced adenocarcinoma of the colon and rectum: a Southeastern Cancer Study Group trial.

  1986cited by this paper
• The effect of platinum binding on the structure of DNA and its function in RNA synthesis

  1978cited by this paper
• Interaction of Pt(II) complexes with DNAs from various sources. A circular dichroism study.

  1977cited by this paper
• Studies on the antitumor activity of group VIII transition metal complexes. Part I. Platinum (II) complexes

  1973cited by this paper

• Structural Features and Photophysical and Antiproliferative Properties of Me2N‑pbt-Cycloplatinated Complexes with Picolinate Ligands

  2025cites this paper
• Beryllium Oxide (Be12O12) as a Nanocarrier for Cisplatin Anticancer Drug and Some of Its Analogs: A DFT Investigation

  2024cites this paper
• Dibromo- and Dichlorotriphenylphosphino N-Acyclic Carbene Complexes of Platinum(II)—Synthesis and Cytotoxicity

  2023cites this paper
• On the Use of Graphene Nanosheets for Drug Delivery: A Case Study of Cisplatin and Some of Its Analogs

  2023cites this paper
• Dibromo–Isonitrile and N-acyclic Carbene Complexes of Platinum(II): Synthesis and Reactivity

  2023cites this paper
• New Platinum(II) Complexes Affecting Different Biomolecular Targets in Resistant Ovarian Carcinoma Cells

  2021cites this paper
• Reactions of cisplatin and cis-[PtI2(NH3)2] with molecular models of relevant protein sidechains: A comparative analysis.

  2020cites this paper
• An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the PtII Linker Lx for Improved Manufacturability of Antibody–Drug Conjugates

  2020cites this paper
• Platinum iodido complexes: A comprehensive overview of anticancer activity and mechanisms of action

  2019cites this paper
• Spectroscopie de luminescence et Raman de matériaux moléculaires cristallins et modélisation par la théorie de la fonctionnelle de la densité

  2019cites this paper
• Chlorido and bromido oxaliplatin analogues as potential agents for CRC treatment: Solution behavior, protein binding and cytotoxicity evaluation

  2018cites this paper
• Mononuclear Pd(II) and Pt(II) complexes with an α-N-heterocyclic thiosemicarbazone: cytotoxicity, solution behaviour and interaction versus proven models from biological media

  2018cites this paper
• PtI2(DACH), the iodido analogue of oxaliplatin as a candidate for colorectal cancer treatment: chemical and biological features.

  2017cites this paper
• Interactions of cisplatin analogues with lysozyme: a comparative analysis

  2017cites this paper
• Characterization and cytotoxic effect of aqua-(2,2′,2′′-nitrilotriacetato)-oxo-vanadium salts on human osteosarcoma cells

  2017cites this paper